A Revolution in Infection Control & Prevention
The Microsafe Technology behind the Nanocyn® Disinfectant & Sanitiser is the original, patented biotech breakthrough. For almost 20 years we are leading our technology sector with the most approvals and independent testing. It is the world’s first and only shelf-stable product of its kind which is entered in the Australian TGA (Therapeutic Goods Administration) ARTG as a “Registered, Hospital Grade Disinfectant” and approved to kill both enveloped (COVID-19) and non-enveloped viruses (Norovirus) within 30 seconds.
About The Technology
The patented Microcyn Technology is the result of almost 20 years of research. It is tested and proven as a fast-acting, non toxic solution for rapid and effective infection control. It requires no dilution or mixing and does not require any special handling or disposal. Nanocyn is non-toxic and safe for the environment and the most approved all-natural disinfectant in the world.
The Standard
Nanocyn® can eliminate viruses and bactiera within 30 seconds of contact by disinfecting not only hard surfaces but also the entire airspace, making it the first choice for hospitals, healthcare providers as well as many other industries in many countries. No other product allows the fumigation of an entire room with people present, which results in enormous cost and time savings. Nanocyn® is far superior to steam, UV-Light or toxic hydrogen peroxide solutions due to its non-toxic and non-corrosive properties. Nanocyn® is the benchmark for infection control.
Proven Benefits
Immediate & significant reduction of harmful viruses and bacteria, as well as odour elimination, is achieved by fumigating key areas throughout any facility. The rapid and efficient application ensures no interruption to day to day operations. Efficient – Safe – Effective. The Microcyn® Technology is backed globally by over 30 clinical studies and papers and has earned numerous international accreditations and endorsements. Nanocyn® kills 99.9999% of viruses and bacteria in 30 seconds, including antibiotic-resistant MRSA, SARS-CoV-2 (COVID-19) and Noroviruses.